在优化的广泛耐药结核病治疗方案中使用贝达喹啉18个月的有效性和安全性的首次经验。
First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB.
作者信息
Lewis Joseph M, Hine Paul, Walker Jenny, Khoo Saye H, Taegtmeyer Miriam, Squire S Bertel, Sloan Derek J
机构信息
Tropical and Infectious Diseases Unit, Royal Liverpool University Hospital, Liverpool, UK Wellcome Trust Liverpool Glasgow Centre for Global Health Research, University of Liverpool, Liverpool, UK
Tropical and Infectious Diseases Unit, Royal Liverpool University Hospital, Liverpool, UK.
出版信息
Eur Respir J. 2016 May;47(5):1581-4. doi: 10.1183/13993003.01980-2015. Epub 2016 Feb 25.
Abstract
摘要
这看起来是一个网址链接，无法直接翻译为中文，保留原文“http://ow.ly/XE34x”
Zotero 插件